AI assistant
Sending…
ANGIODYNAMICS INC — Director's Dealing 2012
Dec 19, 2012
32939_dirs_2012-12-19_410c83bf-f3ba-4f72-8166-ff4ff5597db9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2012-12-17
Reporting Person: Bourne George W. IV (SVP and CT&OO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-12-17 | Common Stock | A | 2000 | — | Acquired | 12000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-12-17 | Non-Qualified Stock Option (right to buy) | $10.87 | A | 5000 | Acquired | 2019-12-17 | Common Stock (5000) | Direct |
Footnotes
F1: The acquisition of 2,000 shares of common stock represents 2,000 restricted stock units, each of which represents a contingent right to receive one share of AngioDynamics, Inc. common stock. The restricted stock units vest in four equal annual installments beginning on 12/17/2013.
F2: Options for 25% of the shares are each exercisable on 12/17/2013, 12/17/2014, 12/17/2015 and 12/17/2016, respectively.
More from ANGIODYNAMICS INC
Legal Proceedings Report
2026
Apr 23
Interim / Quarterly Report
2026
Apr 2
Regulatory Filings
2026
Apr 2
Major Shareholding Notification
2026
Mar 26
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Feb 10
Board/Management Information
2026
Feb 3
Investor Presentation
2026
Jan 14
Major Shareholding Notification
2026
Jan 8
Earnings Release
2026
Jan 6